For the quarter ending 2025-12-31, NMTC has $8,577,602 in assets. $2,175,677 in debts. $3,561,616 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 3,561,616 | 6,570,382 | 8,039,683 | |
| Accounts receivable | 2,661,867 | 1,264,805 | 0 | |
| Inventory, net | 1,666,147 | 2,226,805 | 1,897,701 | |
| Deferred offering costs | 22,920 | 22,920 | 0 | |
| Prepaid expenses | 154,527 | 141,372 | 233,363 | |
| Total current assets | 8,067,077 | 10,226,284 | 10,170,747 | |
| Intangible assets, net | 39,368 | 44,946 | 50,525 | |
| Right-of-use asset | 226,251 | 255,195 | 283,621 | |
| Property and equipment, net | 244,906 | 259,222 | 314,588 | |
| Total assets | 8,577,602 | 10,785,647 | 10,819,481 | |
| Accounts payable | 552,332 | 1,010,369 | 467,734 | |
| Accrued expenses and other liabilities | 706,112 | 1,292,714 | 958,056 | |
| Total current liabilities | 1,258,444 | 2,303,083 | 1,425,790 | |
| Warrant liability | 806,859 | 1,266,894 | - | |
| Operating lease liability, long term | 110,374 | 143,148 | 175,344 | |
| Warrant liability | - | - | 1,040,894 | |
| Total liabilities | 2,175,677 | 3,713,125 | 2,642,028 | |
| Common stock, 0.001 par value 100,000,000 shares authorized 50,413,148 and 50,006,464 shares issued and outstanding as of december 31, 2025 and september 30, 2025, respectively | 50,413 | 50,006 | 49,825 | |
| Additional paidin capital | 86,399,189 | 85,632,303 | 85,118,194 | |
| Accumulated deficit | -80,047,677 | -78,609,787 | -76,990,566 | |
| Total stockholders equity | 6,401,925 | 7,072,522 | 8,177,453 | |
| Total liabilities and stockholders equity | 8,577,602 | 10,785,647 | 10,819,481 | |
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)